Breaking News

Vince & Associates Opens Neuropsych Center

New center in KS to provide study recruitment, medical management, oversight in CNS studies

Vince & Associates Clinical Research has opened its dedicated Neuropsychiatric Research Center in Overland Park, KS. This research facility will support clients by providing effective study recruitment, medical management and oversight in study volunteers across a range of neuropsychiatric disorders including both acute and chronic schizophrenia, according to a company statement.

“While Vince & Associates has been conducting clinical trials in schizophrenia over the past decade, this dedicated unit will allow us to better serve the needs of both study volunteers and our biopharmaceutical clients,” said Dr. Brad Vince, the company’s president and medical director.

Debra Kelsh, MD, a board-certified psychiatrist and an investigator in more than 300 clinical trials, will serve as medical director of the new Neuropsychiatric Research Center. “The safety and security of our study volunteers was highly emphasized during the design of the unit,” said Dr. Kelsh.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters